One (1) pharmagard NU-PR797-400 compounding aeptic isolator
Ended Awarded
- Contract number
- HT009026FG1010050
- Awardee
-
Nuaire Inc. UEI WEZ2ZMZBLRV3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $20,047
Award facts
- Contract value 100% obligated
- $20,047.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 337127 Institutional Furniture Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55447, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a delivery order to Nuaire Inc. on October 1, 2025, for the procurement of one Pharmagard NU-PR797-400 Compounding Aseptic Isolator, with a ceiling value of $20,047.49. This contract is issued under Nuaire's General Services Administration (GSA) Multiple Award Schedule (MAS) contract, which streamlines procurement processes for federal agencies seeking specialized laboratory equipment. The work will be performed at Nuaire's headquarters in Plymouth, Minnesota, with an ultimate completion date of September 30, 2026. No small business set-aside designation was applied to this award.
Nuaire Inc., a for-profit manufacturer of biomedical and microbiological laboratory equipment, has an established track record serving the Defense Health Agency and other federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Defense. The Pharmagard aseptic isolator is a critical piece of pharmaceutical compounding equipment used in controlled environments to prepare sterile pharmaceutical compounds while protecting both the product and the operator. This delivery order aligns with the Defense Health Agency's mission to support medical readiness and healthcare operations across the Department of Defense by supplying essential laboratory infrastructure and pharmaceutical preparation capabilities.
Quick answers
Who was awarded contract HT009026FG1010050?
HT009026FG1010050 was awarded to Nuaire Inc. by Defense Health Agency (Department of Defense) on October 1, 2025.
How much is contract HT009026FG1010050 worth?
The government has obligated $20,047 on HT009026FG1010050.
Is contract HT009026FG1010050 an order under another contract?
Yes. HT009026FG1010050 is a delivery order under GS07F226BA, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract HT009026FG1010050 competed?
The extent of competition for HT009026FG1010050 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award